Avastin Alternatives Compared
| Avastin (bevacizumab) | Opdivo Qvantig (hyaluronidase / nivolumab) | Oxaliplatin |
|
|---|
| Avastin (bevacizumab) | Opdivo Qvantig (hyaluronidase / nivolumab) | Oxaliplatin |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Glioblastoma Multiforme, Colorectal Cancer, Fallopian Tube Cancer, Cervical Cancer, Hepatocellular Carcinoma, Non Small Cell Lung Cancer, Ovarian Cancer, Peritoneal Cancer, Renal Cell... View more |
Prescription only
Prescribed for Colorectal Cancer, Esophageal Carcinoma, Gastric Cancer, Head and Neck Cancer, Hepatocellular Carcinoma, Melanoma, Non Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial... View more |
Prescription only
Prescribed for Colorectal Cancer. Oxaliplatin may also be used for purposes not listed in this medication guide. |
Related suggestions Colorectal Cancer
|
|||||||||||||||||||||||
| More about Avastin (bevacizumab) | More about Opdivo Qvantig (hyaluronidase / nivolumab) | More about Oxaliplatin | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Avastin has an average rating of 7.5 out of 10 from a total of 30 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 13% reported a negative effect. |
Be the first to share your experience with this drug. |
Oxaliplatin has an average rating of 4.0 out of 10 from a total of 5 ratings on Drugs.com. 20% of reviewers reported a positive effect, while 60% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Avastin side effects |
View all Opdivo Qvantig side effects |
View all Oxaliplatin side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
N/A |
Lower cost generic |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Avastin prices |
View all Opdivo Qvantig prices |
View all Oxaliplatin prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other bevacizumab brands include: Alymsys, Avzivi, Jobevne, Mvasi, Vegzelma, Zirabev |
N/A |
Eloxatin | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
480 hours |
640.8 hours |
391 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 54 drugs are known to interact with Avastin:
|
A total of 668 drugs are known to interact with Opdivo Qvantig:
|
A total of 636 drugs are known to interact with Oxaliplatin:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
February 26, 2004 |
December 27, 2024 |
N/A |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Temodar
Temodar (temozolomide) used to treat certain cancerous brain tumors in adult patients. Learn about ...
Mvasi
Mvasi is used for cervical cancer, colorectal cancer, fallopian tube cancer, glioblastoma ...
Vegzelma
Vegzelma is used for cervical cancer, colorectal cancer, fallopian tube cancer, glioblastoma ...
Alymsys
Alymsys is used for cervical cancer, colorectal cancer, fallopian tube cancer, glioblastoma ...
Avzivi
Avzivi (bevacizumab-tnjn) is a vascular endothelial growth factor (VEGF) inhibitor biosimilar to ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.